Skip to main content
Erschienen in: Current Psychiatry Reports 12/2013

01.12.2013 | Anxiety Disorders (DJ Stein, Section Editor)

Translational Approaches to Anxiety: Focus on Genetics, Fear Extinction and Brain Imaging

verfasst von: Angelika Erhardt, Victor I. Spoormaker

Erschienen in: Current Psychiatry Reports | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Anxiety disorders are highly prevalent and debilitating psychiatric disorders. Owing to the complex aetiology of anxiety disorders, translational studies involving multiple approaches, including human and animal genetics, molecular, endocrinological and imaging studies, are needed to get a converging picture of function or dysfunction of anxiety-related circuits. An advantage of anxiety disorders is that the neural circuitry of fear is comparatively well understood, with striking analogies between animal and human models, and this article aims to provide a brief overview of current translational approaches to anxiety. Experimental models that involve similar tasks in animals and humans, such as fear conditioning and extinction, seem particularly promising and can be readily integrated with imaging, behavioural and physiological readouts. The cross-validation between animal and human genetics models is essential to examine the relevance of candidate genes, as well as their neural pathways, for anxiety disorders; a recent example of such cross-validation work is provided by preclinical and clinical work on TMEM132D, which has been identified as a candidate gene for panic disorder. Further integration of epigenetic data and gene × environment interaction are promising approaches, as highlighted by FKPB5 and PACAP, early life trauma and stress-related anxiety disorders. Finally, connecting genetic and epigenetic data with functionally relevant imaging readouts will allow a comparison of overlap and differences across species in mechanistic pathways from genes to brain functioning and behaviour.
Literatur
1.
Zurück zum Zitat Bateson M, Brilot B, Nettle D. Anxiety: an evolutionary approach. Can J Psychiatry. 2011;56:707–15.PubMed Bateson M, Brilot B, Nettle D. Anxiety: an evolutionary approach. Can J Psychiatry. 2011;56:707–15.PubMed
2.
Zurück zum Zitat Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology. 2009;35:105–35. Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology. 2009;35:105–35.
3.
Zurück zum Zitat Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:593–602.PubMed Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:593–602.PubMed
4.
Zurück zum Zitat Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655–79.PubMed Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655–79.PubMed
5.
Zurück zum Zitat Domschke K, Deckert J. Genetics of anxiety disorders – status quo and quo vadis. Curr Pharm Des. 2012;18:5691–8.PubMed Domschke K, Deckert J. Genetics of anxiety disorders – status quo and quo vadis. Curr Pharm Des. 2012;18:5691–8.PubMed
6.
Zurück zum Zitat Nugent NR, Tyrka AR, Carpenter LL, Price LH. Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology (Berl). 2011;214:175–96.PubMed Nugent NR, Tyrka AR, Carpenter LL, Price LH. Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology (Berl). 2011;214:175–96.PubMed
7.
Zurück zum Zitat Erhardt A, Ising M, Unschuld PG, Kern N, Lucae S, Putz B, et al. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology. 2006;31:2515–22.PubMed Erhardt A, Ising M, Unschuld PG, Kern N, Lucae S, Putz B, et al. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology. 2006;31:2515–22.PubMed
8.
Zurück zum Zitat Keck ME, Wigger A, Welt T, Muller MB, Gesing A, Reul J, et al. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: Implications for pathogenesis of affective disorders. Neuropsychopharmacology. 2002;26:94–105.PubMed Keck ME, Wigger A, Welt T, Muller MB, Gesing A, Reul J, et al. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: Implications for pathogenesis of affective disorders. Neuropsychopharmacology. 2002;26:94–105.PubMed
9.
Zurück zum Zitat Ludewig S, Geyer MA, Ramseier M, Vollenweider FX, Rechsteiner E, Cattapan-Ludewig K. Information-processing deficits and cognitive dysfunction in panic disorder. J Psychiatry Neurosci. 2005;30:37–43.PubMed Ludewig S, Geyer MA, Ramseier M, Vollenweider FX, Rechsteiner E, Cattapan-Ludewig K. Information-processing deficits and cognitive dysfunction in panic disorder. J Psychiatry Neurosci. 2005;30:37–43.PubMed
10.
Zurück zum Zitat Sartori SB, Hauschild M, Bunck M, Gaburro S, Landgraf R, Singewald N. Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions. PLoS One. 2010;6:e16849. Sartori SB, Hauschild M, Bunck M, Gaburro S, Landgraf R, Singewald N. Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions. PLoS One. 2010;6:e16849.
11.
Zurück zum Zitat Sokolowska E, Hovatta I. Anxiety genetics – findings from cross-species genome-wide approaches. Biol Mood Anxiety Disord. 2013;3:9.PubMed Sokolowska E, Hovatta I. Anxiety genetics – findings from cross-species genome-wide approaches. Biol Mood Anxiety Disord. 2013;3:9.PubMed
12.
Zurück zum Zitat Binder EB, Nemeroff CB. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry. 2010;15:574–88.PubMed Binder EB, Nemeroff CB. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry. 2010;15:574–88.PubMed
13.
Zurück zum Zitat Lin EJ. Neuropeptides as therapeutic targets in anxiety disorders. Curr Pharm Des. 2012;18:5709–27.PubMed Lin EJ. Neuropeptides as therapeutic targets in anxiety disorders. Curr Pharm Des. 2012;18:5709–27.PubMed
14.
Zurück zum Zitat Pape HC, Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev. 2010;90:419–63.PubMed Pape HC, Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev. 2010;90:419–63.PubMed
15.
Zurück zum Zitat Rauch SL, Shin LM, Phelps EA. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research–past, present, and future. Biol Psychiatry. 2006;60:376–82.PubMed Rauch SL, Shin LM, Phelps EA. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research–past, present, and future. Biol Psychiatry. 2006;60:376–82.PubMed
16.
Zurück zum Zitat Pavlov IP. Conditioned reflexes. London: Oxford University Press; 1927. Pavlov IP. Conditioned reflexes. London: Oxford University Press; 1927.
17.
Zurück zum Zitat Rodnick EH. Characteristics of delayed and trace conditioned responses. J Exp Psychol. 1937;20:409–25. Rodnick EH. Characteristics of delayed and trace conditioned responses. J Exp Psychol. 1937;20:409–25.
18.
Zurück zum Zitat Steckle LC. A trace conditioning of the galvanic reflex. Gene Psychol. 1933;9:475–80. Steckle LC. A trace conditioning of the galvanic reflex. Gene Psychol. 1933;9:475–80.
19.
Zurück zum Zitat Switzer SA. Anticipatory and inhibitory characteristics of delayed conditioned reactions. J Exp Psychol. 1934;17:603–20. Switzer SA. Anticipatory and inhibitory characteristics of delayed conditioned reactions. J Exp Psychol. 1934;17:603–20.
20.
Zurück zum Zitat Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, Grillon C, et al. Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther. 2005;43:1391–424.PubMed Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, Grillon C, et al. Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther. 2005;43:1391–424.PubMed
21.
Zurück zum Zitat Reinhard G, Lachnit H, König S. Tracking stimulus processing in Pavlovian pupillary conditioning. Psychophys. 2006;43:73–83. Reinhard G, Lachnit H, König S. Tracking stimulus processing in Pavlovian pupillary conditioning. Psychophys. 2006;43:73–83.
22.••
Zurück zum Zitat Milad MR, Quirk GJ. Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol. 2012;63:129–51. Comprehensive review of the progress made by neuroscientific research on fear extinction in the last decade written by two leading authors in the field, highlighting the translational success of fear extinction, which is proposed to be a translational model for neuroscience.PubMed Milad MR, Quirk GJ. Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol. 2012;63:129–51. Comprehensive review of the progress made by neuroscientific research on fear extinction in the last decade written by two leading authors in the field, highlighting the translational success of fear extinction, which is proposed to be a translational model for neuroscience.PubMed
23.
Zurück zum Zitat Büchel C, Morris J, Dolan RJ, Friston KJ. Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron. 1998;20:947–57.PubMed Büchel C, Morris J, Dolan RJ, Friston KJ. Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron. 1998;20:947–57.PubMed
24.
Zurück zum Zitat LaBar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron. 1998;20:937–45.PubMed LaBar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron. 1998;20:937–45.PubMed
25.
Zurück zum Zitat Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164:1476–88.PubMed Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164:1476–88.PubMed
26.
Zurück zum Zitat Sehlmeyer C, Schöning S, Zwitserlood P, Pfleiderer B, Kircher T, Arolt V, et al. Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS One. 2009;4:e5865.PubMed Sehlmeyer C, Schöning S, Zwitserlood P, Pfleiderer B, Kircher T, Arolt V, et al. Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS One. 2009;4:e5865.PubMed
27.
Zurück zum Zitat Spoormaker VI, Andrade KC, Schröter MS, Sturm A, Goya-Maldonado R, Sämann PG, et al. The neural correlates of negative prediction error signaling in human fear conditioning. Neuroimage. 2011;54:2250–6.PubMed Spoormaker VI, Andrade KC, Schröter MS, Sturm A, Goya-Maldonado R, Sämann PG, et al. The neural correlates of negative prediction error signaling in human fear conditioning. Neuroimage. 2011;54:2250–6.PubMed
28.
Zurück zum Zitat Kalisch R, Korenfeld E, Stephan KE, Weiskopf N, Seymour B, Dolan RJ. Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. J Neurosci. 2006;26:9503–11.PubMed Kalisch R, Korenfeld E, Stephan KE, Weiskopf N, Seymour B, Dolan RJ. Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. J Neurosci. 2006;26:9503–11.PubMed
29.
Zurück zum Zitat Phelps EA. Human emotion and memory: interactions of the amygdala and hippocampal complex. Curr Opin Neurobiol. 2004;14:198–202.PubMed Phelps EA. Human emotion and memory: interactions of the amygdala and hippocampal complex. Curr Opin Neurobiol. 2004;14:198–202.PubMed
30.
Zurück zum Zitat Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry. 2007;62:446–54.PubMed Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry. 2007;62:446–54.PubMed
31.
Zurück zum Zitat Vertes RP. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse. 2004;51:32–58.PubMed Vertes RP. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse. 2004;51:32–58.PubMed
32.
Zurück zum Zitat Milad MR, Quirk GJ. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature. 2002;420:70–4.PubMed Milad MR, Quirk GJ. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature. 2002;420:70–4.PubMed
33.
Zurück zum Zitat Burgos-Robles A, Vidal-Gonzalez I, Quirk GJ. Sustained conditioned responses in prelimbic prefrontal neurons are correlated with fear expression and extinction failure. J Neurosci. 2009;29:8474–82.PubMed Burgos-Robles A, Vidal-Gonzalez I, Quirk GJ. Sustained conditioned responses in prelimbic prefrontal neurons are correlated with fear expression and extinction failure. J Neurosci. 2009;29:8474–82.PubMed
34.
Zurück zum Zitat Pitman RK, Rasmusson AM, Koenen KC, Shin LM, Orr SP, Gilbertson MW, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci. 2012;13:769–87.PubMed Pitman RK, Rasmusson AM, Koenen KC, Shin LM, Orr SP, Gilbertson MW, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci. 2012;13:769–87.PubMed
35.
Zurück zum Zitat Blechert J, Michael T, Vriends N, Margraf J, Wilhelm FH. Fear conditioning in posttraumatic stress disorder: evidence for delayed extinction of autonomic, experiential, and behavioural responses. Behav Res Ther. 2007;45:2019–33.PubMed Blechert J, Michael T, Vriends N, Margraf J, Wilhelm FH. Fear conditioning in posttraumatic stress disorder: evidence for delayed extinction of autonomic, experiential, and behavioural responses. Behav Res Ther. 2007;45:2019–33.PubMed
36.
Zurück zum Zitat Milad MR, Pitman RK, Ellis CB, Gold AL, Shin LM, Lasko NB, et al. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry. 2009;66:1075–82.PubMed Milad MR, Pitman RK, Ellis CB, Gold AL, Shin LM, Lasko NB, et al. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry. 2009;66:1075–82.PubMed
37.
Zurück zum Zitat Wessa M, Flor H. Failure of extinction of fear responses in posttraumatic stress disorder: evidence from second-order conditioning. Am J Psychiatry. 2007;164:1684–92.PubMed Wessa M, Flor H. Failure of extinction of fear responses in posttraumatic stress disorder: evidence from second-order conditioning. Am J Psychiatry. 2007;164:1684–92.PubMed
38.
Zurück zum Zitat Hayes JP, Hayes SM, Mikedis AM. Quantitative meta-analysis of neural activity in posttraumatic stress disorder. Biol Mood Anxiety Disord. 2012;2:9.PubMed Hayes JP, Hayes SM, Mikedis AM. Quantitative meta-analysis of neural activity in posttraumatic stress disorder. Biol Mood Anxiety Disord. 2012;2:9.PubMed
39.
Zurück zum Zitat Dresler T, Guhn A, Tupak SV, Ehlis AC, Herrmann MJ, Fallgatter AJ, et al. Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm. 2013;120:3–29.PubMed Dresler T, Guhn A, Tupak SV, Ehlis AC, Herrmann MJ, Fallgatter AJ, et al. Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm. 2013;120:3–29.PubMed
40.
Zurück zum Zitat Lissek S. Toward an account of clinical anxiety predicated on basic, neurally mapped mechanisms of Pavlovian fear-learning: the case for conditioned overgeneralization. Depress Anxiety. 2012;29:257–63.PubMed Lissek S. Toward an account of clinical anxiety predicated on basic, neurally mapped mechanisms of Pavlovian fear-learning: the case for conditioned overgeneralization. Depress Anxiety. 2012;29:257–63.PubMed
41.
Zurück zum Zitat Karl A, Schaefer M, Malta LS, Dörfel D, Rohleder N, Werner A. A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev. 2006;30:1004–31.PubMed Karl A, Schaefer M, Malta LS, Dörfel D, Rohleder N, Werner A. A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev. 2006;30:1004–31.PubMed
42.
Zurück zum Zitat Ioannidis JP. Excess significance bias in the literature on brain volume abnormalities. Arch Gen Psychiatry. 2011;68:773–80.PubMed Ioannidis JP. Excess significance bias in the literature on brain volume abnormalities. Arch Gen Psychiatry. 2011;68:773–80.PubMed
43.
Zurück zum Zitat Pohlack ST, Nees F, Liebscher C, Cacciaglia R, Diener SJ, Ridder S, et al. Hippocampal but not amygdalar volume affects contextual fear conditioning in humans. Hum Brain Mapp. 2012;33:478–88.PubMed Pohlack ST, Nees F, Liebscher C, Cacciaglia R, Diener SJ, Ridder S, et al. Hippocampal but not amygdalar volume affects contextual fear conditioning in humans. Hum Brain Mapp. 2012;33:478–88.PubMed
44.
Zurück zum Zitat Lang PJ. The cognitive psychophysiology of emotion: Fear and anxiety. In: Tuma AH, Maser JD, editors. Anxiety and the anxiety disorders. Hillsdale, NJ: Erlbaum; 1985. p. 130–70. Lang PJ. The cognitive psychophysiology of emotion: Fear and anxiety. In: Tuma AH, Maser JD, editors. Anxiety and the anxiety disorders. Hillsdale, NJ: Erlbaum; 1985. p. 130–70.
45.
Zurück zum Zitat Beckers T, Krypotos AM, Boddez Y, Effting M, Kindt M. What's wrong with fear conditioning? Biol Psychol. 2013;92:90–6.PubMed Beckers T, Krypotos AM, Boddez Y, Effting M, Kindt M. What's wrong with fear conditioning? Biol Psychol. 2013;92:90–6.PubMed
46.
Zurück zum Zitat Grillon C, Baas JMP, Cornwell B, Johnson L. Context conditioning and behavioral avoidance in a virtual reality environment: effect of predictability. Biol Psychiatry. 2006;60:752–9.PubMed Grillon C, Baas JMP, Cornwell B, Johnson L. Context conditioning and behavioral avoidance in a virtual reality environment: effect of predictability. Biol Psychiatry. 2006;60:752–9.PubMed
47.
Zurück zum Zitat Cornwell BR, Overstreet C, Krimsky M, Grillon C. Passive avoidance is linked to impaired fear extinction in humans. Learn Memory. 2013;20:164–9. Cornwell BR, Overstreet C, Krimsky M, Grillon C. Passive avoidance is linked to impaired fear extinction in humans. Learn Memory. 2013;20:164–9.
48.••
Zurück zum Zitat Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297:400–3. Initial study employing a functional imaging endophenotype approach on serotonin transporter gene variation in relation to amygdala response to emotional faces.PubMed Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297:400–3. Initial study employing a functional imaging endophenotype approach on serotonin transporter gene variation in relation to amygdala response to emotional faces.PubMed
49.
Zurück zum Zitat Munafò MR, Brown SM, Hariri AR. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry. 2008;63:852–7.PubMed Munafò MR, Brown SM, Hariri AR. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry. 2008;63:852–7.PubMed
50.
Zurück zum Zitat Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J, et al. Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol. 2006;9:349–55.PubMed Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J, et al. Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol. 2006;9:349–55.PubMed
51.
Zurück zum Zitat Furmark T, Henningsson S, Appel L, Ahs F, Linnman C, Pissiota A, et al. Genotype over-diagnosis in amygdala responsiveness: affective processing in social anxiety disorder. J Psychiatry Neurosci. 2009;34:30–40.PubMed Furmark T, Henningsson S, Appel L, Ahs F, Linnman C, Pissiota A, et al. Genotype over-diagnosis in amygdala responsiveness: affective processing in social anxiety disorder. J Psychiatry Neurosci. 2009;34:30–40.PubMed
52.
Zurück zum Zitat Domschke K, Dannlowski U. Imaging genetics of anxiety disorders. Neuroimage. 2010;53:822–31.PubMed Domschke K, Dannlowski U. Imaging genetics of anxiety disorders. Neuroimage. 2010;53:822–31.PubMed
53.
Zurück zum Zitat Stein MB, Seedat S, Gelernter J. Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology (Berl). 2006;187:68–72.PubMed Stein MB, Seedat S, Gelernter J. Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology (Berl). 2006;187:68–72.PubMed
54.
Zurück zum Zitat Lonsdorf TB, Kalisch R. A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment. Transl Psychiatry. 2011;1:e41.PubMed Lonsdorf TB, Kalisch R. A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment. Transl Psychiatry. 2011;1:e41.PubMed
55.
Zurück zum Zitat Soliman F, Glatt CE, Bath KG, Levita L, Jones RM, Pattwell SS, et al. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science. 2010;327:863–36.PubMed Soliman F, Glatt CE, Bath KG, Levita L, Jones RM, Pattwell SS, et al. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science. 2010;327:863–36.PubMed
56.
Zurück zum Zitat Raczka KA, Mechias ML, Gartmann N, Reif A, Deckert J, Pessiglione M, et al. Empirical support for an involvement of the mesostriatal dopamine system in human fear extinction. Transl Psychiatry. 2011;1:e12.PubMed Raczka KA, Mechias ML, Gartmann N, Reif A, Deckert J, Pessiglione M, et al. Empirical support for an involvement of the mesostriatal dopamine system in human fear extinction. Transl Psychiatry. 2011;1:e12.PubMed
57.
Zurück zum Zitat Mitchell KJ, Huang ZJ, Moghaddam B, Sawa A. Following the genes: a framework for animal modeling of psychiatric disorders. BMC Biol. 2011;9:76.PubMed Mitchell KJ, Huang ZJ, Moghaddam B, Sawa A. Following the genes: a framework for animal modeling of psychiatric disorders. BMC Biol. 2011;9:76.PubMed
58.
Zurück zum Zitat Muller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci. 2003;6:1100–7.PubMed Muller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci. 2003;6:1100–7.PubMed
59.
Zurück zum Zitat Ernst C, Wanner B, Brezo J, Vitaro F, Tremblay R, Turecki G. A deletion in tropomyosin-related kinase B and the development of human anxiety. Biol Psychiatry. 2011;69:604–7.PubMed Ernst C, Wanner B, Brezo J, Vitaro F, Tremblay R, Turecki G. A deletion in tropomyosin-related kinase B and the development of human anxiety. Biol Psychiatry. 2011;69:604–7.PubMed
60.
Zurück zum Zitat Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet. 2013;14:483–95.PubMed Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet. 2013;14:483–95.PubMed
61.
Zurück zum Zitat Acevedo-Arozena A, Wells S, Potter P, Kelly M, Cox RD, Brown SD. ENU mutagenesis, a way forward to understand gene function. Annu Rev Genomics Hum Genet. 2008;9:49–69.PubMed Acevedo-Arozena A, Wells S, Potter P, Kelly M, Cox RD, Brown SD. ENU mutagenesis, a way forward to understand gene function. Annu Rev Genomics Hum Genet. 2008;9:49–69.PubMed
62.
Zurück zum Zitat Sun M, Mondal K, Patel V, Horner VL, Long AB, Cutler DJ, et al. Multiplex Chromosomal Exome Sequencing Accelerates Identification of ENU-Induced Mutations in the Mouse. G3 (Bethesda). 2012;2:143–50. Sun M, Mondal K, Patel V, Horner VL, Long AB, Cutler DJ, et al. Multiplex Chromosomal Exome Sequencing Accelerates Identification of ENU-Induced Mutations in the Mouse. G3 (Bethesda). 2012;2:143–50.
63.
Zurück zum Zitat Brown SD, Moore MW. The International Mouse Phenotyping Consortium: past and future perspectives on mouse phenotyping. Mamm Genome. 2012;23:632–40.PubMed Brown SD, Moore MW. The International Mouse Phenotyping Consortium: past and future perspectives on mouse phenotyping. Mamm Genome. 2012;23:632–40.PubMed
64.
Zurück zum Zitat Dincheva I, Glatt CE, Lee FS. Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics. Neuroscientist. 2012;18:439–51.PubMed Dincheva I, Glatt CE, Lee FS. Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics. Neuroscientist. 2012;18:439–51.PubMed
65.•
Zurück zum Zitat Bath KG, Chuang J, Spencer-Segal JL, Amso D, Altemus M, McEwen BS, et al. Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice. Biol Psychiatry. 2012;72:499–504. In this study, the authors present an excellent tool of a humanised animal model where human genetic mutations of interest can be assessed in animals on multiple levels leading to a leap in information readout regarding the biological function of a single mutation.PubMed Bath KG, Chuang J, Spencer-Segal JL, Amso D, Altemus M, McEwen BS, et al. Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice. Biol Psychiatry. 2012;72:499–504. In this study, the authors present an excellent tool of a humanised animal model where human genetic mutations of interest can be assessed in animals on multiple levels leading to a leap in information readout regarding the biological function of a single mutation.PubMed
66.
Zurück zum Zitat Nillni YI, Toufexis DJ, Rohan KJ. Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Clin Psychol Rev. 2011;31:1183–91.PubMed Nillni YI, Toufexis DJ, Rohan KJ. Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Clin Psychol Rev. 2011;31:1183–91.PubMed
67.
Zurück zum Zitat Tocchetto A, Salum GA, Blaya C, Teche S, Isolan L, Bortoluzzi A, et al. Evidence of association between Val66Met polymorphism at BDNF gene and anxiety disorders in a community sample of children and adolescents. Neurosci Lett. 2011;502:197–200.PubMed Tocchetto A, Salum GA, Blaya C, Teche S, Isolan L, Bortoluzzi A, et al. Evidence of association between Val66Met polymorphism at BDNF gene and anxiety disorders in a community sample of children and adolescents. Neurosci Lett. 2011;502:197–200.PubMed
68.
Zurück zum Zitat Klauke B, Winter B, Gajewska A, Zwanzger P, Reif A, Herrmann MJ, et al. Affect-modulated startle: interactive influence of catechol-O-methyltransferase Val158Met genotype and childhood trauma. PLoS One. 2012;7:e39709.PubMed Klauke B, Winter B, Gajewska A, Zwanzger P, Reif A, Herrmann MJ, et al. Affect-modulated startle: interactive influence of catechol-O-methyltransferase Val158Met genotype and childhood trauma. PLoS One. 2012;7:e39709.PubMed
69.
Zurück zum Zitat Desbonnet L, Tighe O, Karayiorgou M, Gogos JA, Waddington JL, O'Tuathaigh CM. Physiological and behavioural responsivity to stress and anxiogenic stimuli in COMT-deficient mice. Behav Brain Res. 2012;228:351–8.PubMed Desbonnet L, Tighe O, Karayiorgou M, Gogos JA, Waddington JL, O'Tuathaigh CM. Physiological and behavioural responsivity to stress and anxiogenic stimuli in COMT-deficient mice. Behav Brain Res. 2012;228:351–8.PubMed
70.
Zurück zum Zitat Kim B, Yoo E, Lee JY, Lee KS, Choe AY, Lee JE, et al. The effects of the catechol-O-methyltransferase val158met polymorphism on white matter connectivity in patients with panic disorder. J Affect Disord. 2013;147:64–71.PubMed Kim B, Yoo E, Lee JY, Lee KS, Choe AY, Lee JE, et al. The effects of the catechol-O-methyltransferase val158met polymorphism on white matter connectivity in patients with panic disorder. J Affect Disord. 2013;147:64–71.PubMed
71.
Zurück zum Zitat Le-Niculescu H, Balaraman Y, Patel SD, Ayalew M, Gupta J, Kuczenski R, et al. Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Transl Psychiatry. 2011;1:e9.PubMed Le-Niculescu H, Balaraman Y, Patel SD, Ayalew M, Gupta J, Kuczenski R, et al. Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Transl Psychiatry. 2011;1:e9.PubMed
72.
Zurück zum Zitat Reif A, Weber H, Domschke K, Klauke B, Baumann C, Jacob CP, et al. Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:786–93.PubMed Reif A, Weber H, Domschke K, Klauke B, Baumann C, Jacob CP, et al. Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:786–93.PubMed
73.
Zurück zum Zitat Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, et al. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol. 2012;166:4–17.PubMed Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, et al. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol. 2012;166:4–17.PubMed
74.
Zurück zum Zitat Hattori S, Takao K, Tanda K, Toyama K, Shintani N, Baba A, et al. Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice. Front Behav Neurosci. 2012;6:58.PubMed Hattori S, Takao K, Tanda K, Toyama K, Shintani N, Baba A, et al. Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice. Front Behav Neurosci. 2012;6:58.PubMed
75.
Zurück zum Zitat Otto C, Kovalchuk Y, Wolfer DP, Gass P, Martin M, Zuschratter W, et al. Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice. J Neurosci. 2001;21:5520–7.PubMed Otto C, Kovalchuk Y, Wolfer DP, Gass P, Martin M, Zuschratter W, et al. Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice. J Neurosci. 2001;21:5520–7.PubMed
76.
Zurück zum Zitat Otto C, Martin M, Wolfer DP, Lipp HP, Maldonado R, Schutz G. Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res Mol Brain Res. 2001;92:78–84.PubMed Otto C, Martin M, Wolfer DP, Lipp HP, Maldonado R, Schutz G. Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res Mol Brain Res. 2001;92:78–84.PubMed
77.••
Zurück zum Zitat Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature. 2011;470:492–7. This study shows the advantage of integrated translational research for the investigation of biological functions of a candidate gene.PubMed Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature. 2011;470:492–7. This study shows the advantage of integrated translational research for the investigation of biological functions of a candidate gene.PubMed
78.
Zurück zum Zitat Almli LM, Mercer KB, Kerley K, Feng H, Bradley B, Conneely KN, et al. ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females. Am J Med Genet B Neuropsychiatr Genet. 2013;162B:262–72.PubMed Almli LM, Mercer KB, Kerley K, Feng H, Bradley B, Conneely KN, et al. ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females. Am J Med Genet B Neuropsychiatr Genet. 2013;162B:262–72.PubMed
79.
Zurück zum Zitat Wang L, Cao C, Wang R, Qing Y, Zhang J, Zhang XY. PAC1 receptor (ADCYAP1R1) genotype is associated with PTSD's emotional numbing symptoms in Chinese earthquake survivors. J Affect Disord. 2013;150:156–9.PubMed Wang L, Cao C, Wang R, Qing Y, Zhang J, Zhang XY. PAC1 receptor (ADCYAP1R1) genotype is associated with PTSD's emotional numbing symptoms in Chinese earthquake survivors. J Affect Disord. 2013;150:156–9.PubMed
80.
Zurück zum Zitat Chang SC, Xie P, Anton RF, De Vivo I, Farrer LA, Kranzler HR, et al. No association between ADCYAP1R1 and post-traumatic stress disorder in two independent samples. Mol Psychiatry. 2012;17:239–41.PubMed Chang SC, Xie P, Anton RF, De Vivo I, Farrer LA, Kranzler HR, et al. No association between ADCYAP1R1 and post-traumatic stress disorder in two independent samples. Mol Psychiatry. 2012;17:239–41.PubMed
81.
Zurück zum Zitat Jovanovic T, Norrholm SD, Davis J, Mercer KB, Almli L, Nelson A, et al. PAC1 receptor (ADCYAP1R1) genotype is associated with dark-enhanced startle in children. Mol Psychiatry. 2013;18:742–3.PubMed Jovanovic T, Norrholm SD, Davis J, Mercer KB, Almli L, Nelson A, et al. PAC1 receptor (ADCYAP1R1) genotype is associated with dark-enhanced startle in children. Mol Psychiatry. 2013;18:742–3.PubMed
82.
Zurück zum Zitat Ishihama T, Ago Y, Shintani N, Hashimoto H, Baba A, Takuma K, et al. Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice. Behav Brain Res. 2010;209:274–80.PubMed Ishihama T, Ago Y, Shintani N, Hashimoto H, Baba A, Takuma K, et al. Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice. Behav Brain Res. 2010;209:274–80.PubMed
83.
Zurück zum Zitat Uddin M, Chang SC, Zhang C, Ressler K, Mercer KB, Galea S, et al. Adcyap1r1 genotype, posttraumatic stress disorder, and depression among women exposed to childhood maltreatment. Depress Anxiety. 2013;30:251–8.PubMed Uddin M, Chang SC, Zhang C, Ressler K, Mercer KB, Galea S, et al. Adcyap1r1 genotype, posttraumatic stress disorder, and depression among women exposed to childhood maltreatment. Depress Anxiety. 2013;30:251–8.PubMed
84.
Zurück zum Zitat Otowa T, Yoshida E, Sugaya N, Yasuda S, Nishimura Y, Inoue K, et al. Genome-wide association study of panic disorder in the Japanese population. J Hum Genet. 2009;54:122–6.PubMed Otowa T, Yoshida E, Sugaya N, Yasuda S, Nishimura Y, Inoue K, et al. Genome-wide association study of panic disorder in the Japanese population. J Hum Genet. 2009;54:122–6.PubMed
85.
Zurück zum Zitat Otowa T, Tanii H, Sugaya N, Yoshida E, Inoue K, Yasuda S, et al. Replication of a genome-wide association study of panic disorder in a Japanese population. J Hum Genet. 2010;55:91–6.PubMed Otowa T, Tanii H, Sugaya N, Yoshida E, Inoue K, Yasuda S, et al. Replication of a genome-wide association study of panic disorder in a Japanese population. J Hum Genet. 2010;55:91–6.PubMed
86.
Zurück zum Zitat Otowa T, Kawamura Y, Nishida N, Sugaya N, Koike A, Yoshida E, et al. Meta-analysis of genome-wide association studies for panic disorder in the Japanese population. Transl Psychiatry. 2012;2:e186.PubMed Otowa T, Kawamura Y, Nishida N, Sugaya N, Koike A, Yoshida E, et al. Meta-analysis of genome-wide association studies for panic disorder in the Japanese population. Transl Psychiatry. 2012;2:e186.PubMed
87.
Zurück zum Zitat Gregersen N, Dahl HA, Buttenschon HN, Nyegaard M, Hedemand A, Als TD, et al. A genome-wide study of panic disorder suggests the amiloride-sensitive cation channel 1 as a candidate gene. Eur J Hum Genet. 2012;20:84–90.PubMed Gregersen N, Dahl HA, Buttenschon HN, Nyegaard M, Hedemand A, Als TD, et al. A genome-wide study of panic disorder suggests the amiloride-sensitive cation channel 1 as a candidate gene. Eur J Hum Genet. 2012;20:84–90.PubMed
88.
Zurück zum Zitat Kawamura Y, Otowa T, Koike A, Sugaya N, Yoshida E, Yasuda S, et al. A genome-wide CNV association study on panic disorder in a Japanese population. J Hum Genet. 2012;56:852–6. Kawamura Y, Otowa T, Koike A, Sugaya N, Yoshida E, Yasuda S, et al. A genome-wide CNV association study on panic disorder in a Japanese population. J Hum Genet. 2012;56:852–6.
89.•
Zurück zum Zitat Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, et al. TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry. 2011;16:647–63. First translational validation study of a genome-wide hit for PD.PubMed Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, et al. TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry. 2011;16:647–63. First translational validation study of a genome-wide hit for PD.PubMed
90.
Zurück zum Zitat Erhardt A, Akula N, Schumacher J, Czamara D, Karbalai N, Müller-Myhsok B, et al. Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry. 2012;4:2. Erhardt A, Akula N, Schumacher J, Czamara D, Karbalai N, Müller-Myhsok B, et al. Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry. 2012;4:2.
91.
Zurück zum Zitat Quast C, Altmann A, Weber P, Arloth J, Bader D, Heck A, et al. Rare variants in TMEM132D in a case–control sample for panic disorder. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:896–907.PubMed Quast C, Altmann A, Weber P, Arloth J, Bader D, Heck A, et al. Rare variants in TMEM132D in a case–control sample for panic disorder. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:896–907.PubMed
92.
Zurück zum Zitat Mick E, McGough J, Loo S, Doyle AE, Wozniak J, Wilens TE, et al. Genome-wide association study of the child behavior checklist dysregulation profile. J Am Acad Child Adolesc Psychiatr. 2011;50:807–17. Mick E, McGough J, Loo S, Doyle AE, Wozniak J, Wilens TE, et al. Genome-wide association study of the child behavior checklist dysregulation profile. J Am Acad Child Adolesc Psychiatr. 2011;50:807–17.
93.
Zurück zum Zitat Nomoto H, Yonezawa T, Itoh K, Ono K, Yamamoto K, Oohashi T, et al. Molecular cloning of a novel transmembrane protein MOLT expressed by mature oligodendrocytes. J Biochem. 2003;134:231–8.PubMed Nomoto H, Yonezawa T, Itoh K, Ono K, Yamamoto K, Oohashi T, et al. Molecular cloning of a novel transmembrane protein MOLT expressed by mature oligodendrocytes. J Biochem. 2003;134:231–8.PubMed
94.
Zurück zum Zitat Walser SM, Dedic N, Touma C, Floss T, Wurst W, Holsboer F, et al. TMEM132D-a putative cell adhesion molecule involved in panic disorder. Pharmacopsychiatry. 2011;44. Walser SM, Dedic N, Touma C, Floss T, Wurst W, Holsboer F, et al. TMEM132D-a putative cell adhesion molecule involved in panic disorder. Pharmacopsychiatry. 2011;44.
95.
Zurück zum Zitat Sämann PG, Erhardt A, Hoehn D, Czisch M, Kiem S, Holsboer F, et al. Functional connectivity density mapping to explore TMEM 132D, a new candidate for anxiety phenotypes. 18th annual meeting of the organization for Human Brain Mapping, Beijing, China. 2012. Sämann PG, Erhardt A, Hoehn D, Czisch M, Kiem S, Holsboer F, et al. Functional connectivity density mapping to explore TMEM 132D, a new candidate for anxiety phenotypes. 18th annual meeting of the organization for Human Brain Mapping, Beijing, China. 2012.
96.
Zurück zum Zitat Battaglia M. Gene-environment interaction in panic disorder and posttraumatic stress disorder. Can J Psychiatry. 2013;58:69–75.PubMed Battaglia M. Gene-environment interaction in panic disorder and posttraumatic stress disorder. Can J Psychiatry. 2013;58:69–75.PubMed
97.
Zurück zum Zitat Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013;14:204–20.PubMed Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013;14:204–20.PubMed
98.••
Zurück zum Zitat Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci. 2013;16:33–41. An intriguing molecular study of how epigenetic modifications related to childhood trauma influence the clinical phenotype and the regulation of the endocrine stress system in adulthood.PubMed Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci. 2013;16:33–41. An intriguing molecular study of how epigenetic modifications related to childhood trauma influence the clinical phenotype and the regulation of the endocrine stress system in adulthood.PubMed
99.
Zurück zum Zitat Klengel T, Binder EB. Allele-specific epigenetic modification: a molecular mechanism for gene-environment interactions in stress-related psychiatric disorders? Epigenomics. 2013;5:109–12.PubMed Klengel T, Binder EB. Allele-specific epigenetic modification: a molecular mechanism for gene-environment interactions in stress-related psychiatric disorders? Epigenomics. 2013;5:109–12.PubMed
100.
Zurück zum Zitat Domschke K, Tidow N, Kuithan H, Schwarte K, Klauke B, Ambree O, et al. Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder? Int J Neuropsychopharmacol. 2013;15:1217–28. Domschke K, Tidow N, Kuithan H, Schwarte K, Klauke B, Ambree O, et al. Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder? Int J Neuropsychopharmacol. 2013;15:1217–28.
101.
Zurück zum Zitat Domschke K, Tidow N, Kuithan H, Schwarte K, Klauke B, Ambree O, et al. Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder? Int J Neuropsychopharmacol. 2012:1–12. Domschke K, Tidow N, Kuithan H, Schwarte K, Klauke B, Ambree O, et al. Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder? Int J Neuropsychopharmacol. 2012:1–12.
102.
Zurück zum Zitat Esler M, Eikelis N, Schlaich M, Lambert G, Alvarenga M, Kaye D, et al. Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder. Ann N Y Acad Sci. 2008;1148:338–48.PubMed Esler M, Eikelis N, Schlaich M, Lambert G, Alvarenga M, Kaye D, et al. Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder. Ann N Y Acad Sci. 2008;1148:338–48.PubMed
103.
Zurück zum Zitat Buttenschon HN, Kristensen AS, Buch HN, Andersen JH, Bonde JP, Grynderup M, et al. The norepinephrine transporter gene is a candidate gene for panic disorder. J Neural Transm. 2011;118:969–76.PubMed Buttenschon HN, Kristensen AS, Buch HN, Andersen JH, Bonde JP, Grynderup M, et al. The norepinephrine transporter gene is a candidate gene for panic disorder. J Neural Transm. 2011;118:969–76.PubMed
104.
Zurück zum Zitat O'Connor RM, Dinan TG, Cryan JF. Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression. Mol Psychiatry. 2012;17:359–76.PubMed O'Connor RM, Dinan TG, Cryan JF. Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression. Mol Psychiatry. 2012;17:359–76.PubMed
105.
Zurück zum Zitat Parsons MJ, Grimm C, Paya-Cano JL, Fernandes C, Liu L, Philip VM, et al. Genetic variation in hippocampal microRNA expression differences in C57BL/6 J X DBA/2 J (BXD) recombinant inbred mouse strains. BMC Genomics. 2012;13:476.PubMed Parsons MJ, Grimm C, Paya-Cano JL, Fernandes C, Liu L, Philip VM, et al. Genetic variation in hippocampal microRNA expression differences in C57BL/6 J X DBA/2 J (BXD) recombinant inbred mouse strains. BMC Genomics. 2012;13:476.PubMed
106.
Zurück zum Zitat Haramati S, Navon I, Issler O, Ezra-Nevo G, Gil S, Zwang R, et al. MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J Neurosci. 2011;31:14191–203.PubMed Haramati S, Navon I, Issler O, Ezra-Nevo G, Gil S, Zwang R, et al. MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J Neurosci. 2011;31:14191–203.PubMed
107.
Zurück zum Zitat Muinos-Gimeno M, Guidi M, Kagerbauer B, Martin-Santos R, Navines R, Alonso P, et al. Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat. 2009;30:1062–71.PubMed Muinos-Gimeno M, Guidi M, Kagerbauer B, Martin-Santos R, Navines R, Alonso P, et al. Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat. 2009;30:1062–71.PubMed
108.
Zurück zum Zitat Muinos-Gimeno M, Espinosa-Parrilla Y, Guidi M, Kagerbauer B, Sipila T, Maron E, et al. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol Psychiatry. 2011;69:526–33.PubMed Muinos-Gimeno M, Espinosa-Parrilla Y, Guidi M, Kagerbauer B, Sipila T, Maron E, et al. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol Psychiatry. 2011;69:526–33.PubMed
109.
Zurück zum Zitat Sierra-Mercado D, Padilla-Coreano N, Quirk GJ. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology. 2011;36:529–38.PubMed Sierra-Mercado D, Padilla-Coreano N, Quirk GJ. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology. 2011;36:529–38.PubMed
Metadaten
Titel
Translational Approaches to Anxiety: Focus on Genetics, Fear Extinction and Brain Imaging
verfasst von
Angelika Erhardt
Victor I. Spoormaker
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Current Psychiatry Reports / Ausgabe 12/2013
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-013-0417-9

Weitere Artikel der Ausgabe 12/2013

Current Psychiatry Reports 12/2013 Zur Ausgabe

Schizophrenia and Other Psychotic Disorders (SJ Siegel, Section Editor)

Use of Antipsychotic Medications in Pediatric Populations: What do the Data Say?

Personality Disorders (C Schmahl, Section Editor)

Antisocial Personality Disorder: A Current Review

Eating Disorders (AS Kaplan, Section Editor)

Genetics of Eating Disorders

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.